These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 21418025
21. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity. Koepke J, Ermler U, Warkentin E, Wenzl G, Flecker P. J Mol Biol; 2000 May 05; 298(3):477-91. PubMed ID: 10772864 [Abstract] [Full Text] [Related]
29. Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages. Ma TC, Le Guo, Zhou RH, Wang X, Liu JB, Li JL, Zhou Y, Hou W, Ho WZ. Virology; 2018 Jan 01; 513():91-97. PubMed ID: 29040829 [Abstract] [Full Text] [Related]
30. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors. Weder JK, Hinkers SC. J Agric Food Chem; 2004 Jun 30; 52(13):4219-26. PubMed ID: 15212472 [Abstract] [Full Text] [Related]
31. Inhibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris, L) seeds. Ragg EM, Galbusera V, Scarafoni A, Negri A, Tedeschi G, Consonni A, Sessa F, Duranti M. FEBS J; 2006 Sep 30; 273(17):4024-39. PubMed ID: 16889634 [Abstract] [Full Text] [Related]
33. Glycation affects differently the main soybean Bowman-Birk isoinhibitors, IBB1 and IBBD2, altering their antiproliferative properties against HT29 colon cancer cells. Olías R, Becerra-Rodríguez C, Soliz-Rueda JR, Moreno FJ, Delgado-Andrade C, Clemente A. Food Funct; 2019 Sep 01; 10(9):6193-6202. PubMed ID: 31501839 [Abstract] [Full Text] [Related]
34. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops. Mao Y, Lai C, Vogtentanz G, Schmidt B, Day T, Miller J, Brandon DL, Chen D. Protein J; 2005 Jul 01; 24(5):275-82. PubMed ID: 16284725 [Abstract] [Full Text] [Related]
37. Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity. Gueven N, Dittmann K, Mayer C, Rodemann HP. Int J Radiat Biol; 1998 Feb 01; 73(2):157-62. PubMed ID: 9489562 [Abstract] [Full Text] [Related]
38. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Chen YW, Huang SC, Lin-Shiau SY, Lin JK. Carcinogenesis; 2005 Jul 01; 26(7):1296-306. PubMed ID: 15746161 [Abstract] [Full Text] [Related]
39. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes. Dittmann K, Virsik-Köpp P, Mayer C, Rave-Fränk M, Rodemann HP. Int J Radiat Biol; 2003 Oct 01; 79(10):801-8. PubMed ID: 14630539 [Abstract] [Full Text] [Related]
40. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Kennedy AR. Am J Clin Nutr; 1998 Dec 01; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]